HOLLISTON, MA -- The Li-Fraumeni Syndrome Association (LFSA), dedicated to furthering research and worldwide awareness of the inherited cancer predisposition disorder, celebrates new findings published in the renowned JAMA Oncology journal with implications to better predict cancer risk. First presented at LFSA's 5th International Symposium last year, the concept of analyzing tumor patterns and genetic
With the help of the LFSA Genetic Counseling Advisory Group, the LFSA is proud to announce the new Li-Fraumeni syndrome FAQ sheet. Take a moment to read or share the FAQs with family, friends and care providers. If you have a suggestion or a topic you would like included, please contact us at firstname.lastname@example.org.
The Center for Cancer Research, National Cancer Institute, is in their final phase of their Metformin study and is still accepting participants. Metformin is currently being studied in over sixty clinical trials of cancers including breast, colon, and uterine cancer, among others. This is the first study in patients with Li-Fraumeni Syndrome investigating the effects
As someone recently diagnosed with LFS, I have been wondering about the monitoring for cancer and screening regime for me and my daughter going forward. It seems rather open-ended on the cancer.gov website. Furthermore, the insurance companies don’t seem to recognize the LFS genetic testing as legitimate and categorize it as experimental and thus don’t
My husband tested positive for Li-Fraumini just last month. My question/concern is about my 3 adult children (ages 23, 22, 20) and whether or not they should get tested. Does anyone have anything to share about the pro’s and cons of getting tested? I have already talked to a genetics counselor and gotten their viewpoint.